Hemorrhagic Cystitis Following Hematopoietic Stem Cell Transplantation in Children: A Single Pediatric Center Experience
HC remains a significant and morbid complication after pediatric HSCT. Our findings highlight the need for early identification of high-risk patients and access to timely, multidisciplinary interventions. Multicenter prospective studies are essential to standardize care and improve outcomes in this vulnerable population.
Authors
- Pierluigi Calò (ORCID: https://orcid.org/0000-0002-6867-4031)
- Adriano Salaroli (ORCID: https://orcid.org/0000-0002-9729-6797)
- Stéphane Luyckx
- Laurence Dedeken (ORCID: https://orcid.org/0000-0001-7829-6428)
- Christine Devalck (ORCID: https://orcid.org/0000-0001-8319-8312)
- Pauline Mazilier (ORCID: https://orcid.org/0000-0003-4555-0623)
- Eleonore Powis
- Kornreich Laure
- Diallo Safiatou
Institutions
- Université Libre de Bruxelles (BE)
- Institut Jules Bordet (BE)
- Queen Fabiola Children's University Hospital (BE)
- Queen Astrid Military Hospital (BE)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1002/pbc.32071
- Primary Topic
- Polyomavirus and related diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00